Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network

While the use of next-generation androgen receptor pathway inhibition (ARPI) therapy has significantly increased the survival of patients with metastatic prostate adenocarcinoma (AdPC), several groups have reported a treatment-resistant mechanism, whereby cancer cells can become androgen receptor (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ahn R., Che, Nicole, Lovnicki, Jessica M., Dong, Xuesen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891588/
https://www.ncbi.nlm.nih.gov/pubmed/29666783
http://dx.doi.org/10.3389/fonc.2018.00093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891588/
https://www.ncbi.nlm.nih.gov/pubmed/29666783
http://dx.doi.org/10.3389/fonc.2018.00093

Ejemplares similares